These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 22136885

  • 1. Characterization of 4-[18F]-ADAM as an imaging agent for SERT in non-human primate brain using PET: a dynamic study.
    Chen YA, Huang WS, Lin YS, Cheng CY, Liu RS, Wang SJ, Li IH, Huang SY, Shiue CY, Chen CY, Ma KH.
    Nucl Med Biol; 2012 Feb; 39(2):279-85. PubMed ID: 22136885
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
    Shiue GG, Choi SR, Fang P, Hou C, Acton PD, Cardi C, Saffer JR, Greenberg JH, Karp JS, Kung HF, Shiue CY.
    J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Validation of 4-[18F]-ADAM as a SERT imaging agent using micro-PET and autoradiography.
    Ma KH, Huang WS, Kuo YY, Peng CJ, Liou NH, Liu RS, Hwang JJ, Liu JC, Chen HJ, Shiue CY.
    Neuroimage; 2009 Apr 15; 45(3):687-93. PubMed ID: 19211037
    [Abstract] [Full Text] [Related]

  • 6. Validation of two fluoro-analogues of N,N-dimethyl-2-(2'-amino-4'-hydroxymethyl-phenylthio)benzylamine as serotonin transporter imaging agents using microPET.
    Jarkas N, Voll RJ, Williams L, Goodman MM.
    Nucl Med Biol; 2010 Jul 15; 37(5):593-603. PubMed ID: 20610164
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[¹⁸F]-ADAM/small-animal PET study.
    Shih JH, Ma KH, Chen CF, Cheng CY, Pao LH, Weng SJ, Huang YS, Shiue CY, Yeh MK, Li IH.
    Eur Neuropsychopharmacol; 2016 Jan 15; 26(1):92-104. PubMed ID: 26612383
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
    Jarkas N, McConathy J, Votaw JR, Voll RJ, Malveaux E, Camp VM, Williams L, Goodman RR, Kilts CD, Goodman MM.
    Nucl Med Biol; 2005 Jan 15; 32(1):75-86. PubMed ID: 15691664
    [Abstract] [Full Text] [Related]

  • 11. Preliminary Results on the Long-Term Effects of Dextromethorphan on MDMA-Mediated Serotonergic Deficiency and Volumetric Changes in Primates Based on 4-[18F]-ADAM PET/MRI.
    Yeh SH, Kuo YY, Huang WS, Chiu CH, Yu TH, Ii LGF, Tsai CJ, Cheng CY, Ma KH.
    Front Neurosci; 2022 Jan 15; 16():837194. PubMed ID: 35692422
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non-human primates.
    Huang WS, Ma KH, Cheng CY, Chen CY, Fu YK, Chou YH, Wey SP, Liu JC.
    Nucl Med Commun; 2004 May 15; 25(5):515-9. PubMed ID: 15100512
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [11C]SMe-ADAM, an imaging agent for the brain serotonin transporter: synthesis, pharmacological characterization and microPET studies in rats.
    Zessin J, Deuther-Conrad W, Kretzschmar M, Wüst F, Pawelke B, Brust P, Steinbach J, Bergmann R.
    Nucl Med Biol; 2006 Jan 15; 33(1):53-63. PubMed ID: 16459259
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regulation of Noise-Induced Loss of Serotonin Transporters with Resveratrol in a Rat Model Using 4-[18F]-ADAM/Small-Animal Positron Emission Tomography.
    Li IH, Shih JH, Jhao YT, Chen HC, Chiu CH, Chen CF, Huang YS, Shiue CY, Ma KH.
    Molecules; 2019 Apr 05; 24(7):. PubMed ID: 30959762
    [Abstract] [Full Text] [Related]

  • 18. Characterization of FlipIDAM as a SERT-selective SPECT imaging agent.
    Lemoine L, Lieberman BP, Ploessl K, Zheng P, Kung HF.
    Nucl Med Biol; 2013 Oct 05; 40(7):879-86. PubMed ID: 23856117
    [Abstract] [Full Text] [Related]

  • 19. Carbon-11 HOMADAM: a novel PET radiotracer for imaging serotonin transporters.
    Jarkas N, Votaw JR, Voll RJ, Williams L, Camp VM, Owens MJ, Purselle DC, Bremner JD, Kilts CD, Nemeroff CB, Goodman MM.
    Nucl Med Biol; 2005 Apr 05; 32(3):211-24. PubMed ID: 15820756
    [Abstract] [Full Text] [Related]

  • 20. Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[18F]-ADAM PET Imaging.
    Tsai CJ, Chiu CH, Kuo YY, Huang WS, Yu TH, Flores LG, Yeh SH, Ma KH.
    Int J Mol Sci; 2022 Jun 24; 23(13):. PubMed ID: 35806049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.